INTRODUCTION
As humans grow old, memory function declines. Memory formation is a process based on activity-dependent modification of synapses, also known as synaptic plasticity. It is a condition by which the brain builds neuronal circuits during development and controls cognitive function and complex behaviors in the adult.
(1) Synaptic plasticity is input-specific or synapse-specific where structural and functional modification occurs only in synapses that experience changes in activity. Activity-dependent changes in synaptic strength are considered to be the underlying mechanism of learning and memory. Besides structural changes happening in hippocampal neuronal cells, molecular substances also affect activity-dependent synaptic strength and alter learning and memory. (2, 3) One of these molecular substances is brain derived neurotrophic factor (BDNF). This factor was first purified from the mammalian brain based on its survival-promoting action on dorsal root ganglion cells and was classified as the second member of the neurotrophin family of growth factors. (4) Neurotrophins are a family of secreted proteins that have emerged as important regulators of synaptic plasticity. Neurotrophins are also required for the development of the nervous system of vertebrates. The family also includes neurotrophin 3 (NT3), neurotrophin-4/5, neurotrophin-6 and neurotrophin-7. Brain derived neurotrophic factor is the member of the neurotrophin family that has been extensively studied and has been shown to modulate the development and function of synapses. Some studies show that BDNF facilitates both earlyphase and late-phase long-term potentiation (LTP). (5) Brain derived neurotrophic factor is a small dimeric protein, which will bind and activate, both pre-and post-synaptically, two different transmembrane receptor proteins, the tropomyosin related kinase-B (TrkB) with high affinity and the pan neurotrophin receptor p75 NTR with low affinity. Brain derived neurotrophic factor and TrkB are widely distributed across subregions of the hippocampus and the adult forebrain. (4, 6) Tropomyosin related kinase-B activation by BDNF follows the general pathway for tyrosine kinases receptors and initiates three major cascades of signaling pathways: phospholipase Cγ (PLCγ), phosphatidylinositol-3-kinase (PI 3 K) and the cascade regulated by extracellular signal-regulated kinase (ERK), a member of the mitogen-activated protein kinase (MAPK) family. (7) Several methods to increase BDNF expression have been studied, such as physical exercise and herbal supplementation, e.g. with Centella asiatica (CeA). (8, 9) Centella asiatica is a herbaceous plant, commonly found in South-East Asian countries. The plant grows well in high-humidity areas and is distributed from the subtropics to the tropics. (10) Centella asiatica has been widely used for centuries as a medicinal herbal plant, for various purposes, such as wound healing, brain-stimulating effects, treatment of hypertension, microangiopathy, gastric ulcer, and as a potent antioxidant. (11, 12) Some important chemical constituents found in CeA are triterpenoids and flavonoids. (2, 13) Other studies also highlighted asiaticoside and asiatic acid which are part of the triterpenoids compounds in CeA. (14, 15) Centella asiatica has been shown to be very useful in improving learning and memory; it is also used as a tonic to promote brain growth and improve memory. Studies showed that administration of CeA will enhance neuronal dendrites in rats undergoing growth spurts (16, 17) and shows anti-inflammatory effects on hippocampal neuronal cells. (18) Centella asiatica also functions as antioxidant, helps with the wound healing process, and is able to treat hypertensive microangiopathy. (19) Centella asiatica also has neuroprotective effects by modulating antioxidant and mitochondrial pathways, and improving cognitive function in mice. (20, 21) A previous study by Sari et al. (2) showed that administration of CeA ethanol extract at doses of 300 mg/kgBW and 600 mg/kgBW increases BDNF level in serum. Kamelia et al. (12) showed that administration of CeA leaf extract increases neurogenesis and BDNF levels in hippocampal cell culture from 2-week-old mice. Mirza et al. (22) also showed that administration of CeA ethanol extract for 8 weeks will increase cognitive function in 2-month-old male Wistar rats. These previous studies have shown that CeA extract is capable of increasing BDNF levels in the blood and in hippocampal cell culture, and even improve cognitive and memory functions, but they have not showed the effect of CeA ethanol extract on BDNF protein expression in the hippocampus of adult rats. Our research used male Wistar rats of 6 months of age, which is the equivalent of 18 years in humans. (23) The neurodegenerative process starts when humans reach the age of 18 years, thus it is necessary to take preventive action to reduce the decline of memory function. This study aimed to assess the effect of CeA ethanol extract on the expression of hippocampal BDNF protein that plays a key role in synaptic plasticity and memory function.
METHODS

Research Design
Our research was an in-vivo experimental study, conducted at the Laboratory of Pathological Anatomy, Department of Pathological Anatomy, Faculty of Medicine, Universitas Indonesia from June until September 2017. This experiment was part of a larger research project that tried to explore the potential effect of CeA ethanol extract on proteins that play a role in synaptic plasticity, one of them being BDNF.
Animals
The experiments were conducted using eighteen 6-month-old adult male Wistar rats weighing 300-400 grams, that were bred at Biofarma Laboratory, Bandung. The subjects were divided randomly into three groups: one control/distilled water group and two groups treated with different doses (mg/kg) of CeA ethanol extract: 300 mg/kgBW (CeA300) and 600 mg/kgBW (CeA600).
(2) Two animals were placed in the same cage with food and water available ad libitum and maintained on a 12-hour light and 12-hour dark cycle. The room temperature was maintained at 23 ± 1°C. Animals were acclimatized for one week before treatment, followed by oral administration of CeA ethanol extract and hippocampal isolation at the end of the treatment.
Sample size determination
The sample size was calculated using the Mead equation reference with the total number of animal subjects ranging from 13 to 23 subjects. (24) This experiment used 6 subjects in each group, with a total of 18 animals for 3 groups.
Intervention
Centella asiatica plants were obtained from Cikabayan Field, Bogor Agricultural Institute. The extraction and formulation of CeA was performed at the Spices and Medicinal Plant Research Station (Balai Penelitian Tanaman Rempah dan Obat, Balittro), Bogor. In order to prepare the doses of 300 mg/kgBW and 600 mg/ kgBW, the CeA ethanol extract was freshly diluted with sterile distilled water. The CeA ethanol extract was administered orally for 28 consecutive days with weekly weight-adjusted dose.
Measurement of BDNF protein expression
After a 28-day-administration period of CeA ethanol extract, the rats were decapitated, and the hippocampal tissue was isolated. BDNF protein expression was assessed with an immunohistochemical technique using anti-BDNF antibody (Abcam, EPR1292). BDNF protein expression was then calculated using the ImageJ program.
Statistical analysis
Between-group differences were analyzed by Kruskal-Wallis test and continued with post hoc analysis using the SPSS 22.0 software. The differences were considered statistically significant at a p value of <0.05. 
RESULTS
The results of the immunohistochemical assay are presented in Figure 1 . Cells expressing BDNF show a brownish color. It is apparent that BDNF protein expression level in the control group (Figure 1.B) was the lowest of the three groups. The CeA300 group showed a higher expression level of BDNF (Figure 1 .C) compared to the control group (Figure 1.D) The CeA600 group showed the strongest expression level of BDNF in the CA1 region of the hippocampus. Quantitatively, BDNF protein expression of each treatment group is presented in Figure 2 as mean optical density score. Statistical analysis was conducted to identify any significant difference in each group using Kruskal-Wallis test and continued with MannWhitney post hoc analysis. (Figure 2 ) Figure 2 shows that the control group has the lowest level of BDNF protein expression (1.94±041) compared to groups CeA300 (2.22 ± 0.11) and CeA600 (2.79 ± 0.08). Post hoc analysis showed that there was a significant difference in BDNF protein expression level between the control group and the CeA600 group (p=0.000) and also between the CeA300 group and the CeA600 group (p=0.000). 
DISCUSSION
Brain derived neurotrophic factor, a member of the neurotrophin family, is known as the main regulator in synaptic plasticity. (5, 6, 25) It is also known as a key molecule that has an important role in neuronal differentiation, neuronal survival, and formation of synapses. (26, 27) Centella asiatica extract has been shown to increase learning and memory. (28) Memory is enhanced through facilitation of memory retention, the longer the retention of the memory the better it will be able to increase cognitive function. (29) The memory retention process involves growth and arborization of dendrites in hippocampal neurons. (16, 17) Learning and memory improvement might be connected with the antioxidant, antiinflammatory, and neuroprotective activities of CeA. (22) Centella asiatica has antioxidant potential, thus it can act as a neuroprotector and has been proven to be effective in protecting the rat brain against age-related oxidative damage. (30) Our study showed that administration of CeA ethanol extract increases BDNF protein expression in the hippocampus. Centella asiatica significantly increased the BDNF protein expression in the CeA600 group (compared to the control group, Figure 2 ). This result is consistent with the results of previous studies conducted by Sari et al., (2) Kamelia et al., (12) and Mirza et al. (22) Some of the active ingredients contained in CeA are the triterpenoids and flavonoids. Asiatic acid and asiaticoside have also been highlighted and are parts of the triterpenoids of CeA. (28, 30, 31) Flavonoids in CeA in previous studies have been shown to pass through the blood-brain barrier and enhance cortical blood flow. Increased cerebrovascular function, especially in the hippocampus, a brain region important for memory, may facilitate adult neurogenesis. The enhancement of both short-term or long-term memory is controlled at the molecular level. Four signaling pathways controlling this enhancement process are cAMP-dependent protein kinase (protein kinase A), calcium-calmodulin kinase, protein kinase C, and mitogen-activated protein kinase (MAPK). (32, 33) All four pathways converge to signal to the cAMP-response element-binding protein (CREB), a transcription factor which binds to the promoter regions of many genes associated with memory and synaptic plasticity. With their ability to modulate CREB, flavonoids may modulate the expression of neuronal genes which contain cAMP-response element (CRE) sequences in their promoter region. One such a neuronal gene is the BDNF gene. (33) By increasing the activity of CREB, BDNF protein expression in the hippocampus will increase. (33, 34) When BDNF is released from the presynaptic region, it will bind to its receptor tyrosine kinase B (TrkB) and induce various intracellular signaling pathways.
Our study was able to demonstrate higher BDNF protein expression in the CA1 hippocampal region of the treated groups, but this higher BDNF protein expression does not equate to its activity of binding to its receptor TrkB. Thus, further exploration on BDNF activity, its mechanism of binding to its TrkB receptor and its downstream signaling pathway is needed for further understanding about synaptic plasticity. Next, a study on rats with induced neurodegeneration will also be useful to observe the potential role of CeA in neuroregenerative medicine.
CONCLUSIONS
Administration of CeA ethanol extract increases BDNF protein expression in the CA1 hippocampal region. Thus, the use of CeA is promising for the treatment of neurodegenerative disorders.
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